PLRX — PLIANT THERAPEUTICS INC
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 86 家机构在其最新 13F 申报中持有 PLRX(PLIANT THERAPEUTICS INC),合计申报市值 $52.96M,对应 46.45M 股。按股数计算较上季度增持 4.6%(+1.86M 股),申报市值环比下降 5.2%。持仓集中度较高:前五大持有人占申报市值的 39.8%,前十大的集中度为 58.5%。
与上一季度相比,9 家新建仓位、16 家加仓、24 家减仓、14 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
PLIANT THERAPEUTICS INC(PLRX)的主要机构持有人包括 Paradigm Biocapital Advisors LP、Polar Capital Holdings Plc、First Light Asset Management, LLC,按 13F 申报市值在本页 290 家持有人中排名居前。
PLRX 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 48 | 18.46M | $19.93M | -3.0% |
| Q2 2026 | 86 | 46.45M | $52.96M | +4.6% |
| Q1 2026 | 90 | 44.74M | $56.26M | +11.0% |
| Q4 2025 | 93 | 42.00M | $51.82M | -14.8% |
| Q3 2025 | 92 | 46.08M | $68.20M | +2.5% |
| Q2 2025 | 108 | 48.01M | $55.60M | -10.5% |
| Q1 2025 | 134 | 56.21M | $76.09M | -17.2% |
| Q4 2024 | 153 | 68.69M | $843.46M | -2.7% |
表内 8 个季度中,机构持股合计减少 73%(Q4 2024 → Q3 2026);单季变动最大的是 Q1 2025(-17.2%)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 2.41M | $2.60M | 0.00% | 减持 | |
| 2.05M | $2.22M | 0.00% | 持有 | |
| 2.01M | $2.17M | 0.31% | 增持 | |
| 1.60M | $1.73M | 0.34% | 增持 | |
| 1.55M | $1.67M | 0.89% | 持有 | |
| 1.21M | $1.31M | 0.98% | 减持 | |
| 1.15M | $1.25M | 0.00% | 持有 | |
| 835.12K | $901.93K | 0.00% | 持有 | |
| 706.94K | $763.85K | 0.00% | 增持 | |
| 536.08K | $578.97K | 0.00% | 持有 | |
| 527.31K | $569.00K | 0.00% | 减持 | |
| 414.90K | $448.10K | 0.34% | 增持 | |
| 412.80K | $445.82K | 0.02% | 持有 | |
| 403.38K | $435.65K | 0.31% | 新进 | |
| 385.23K | $416.05K | 0.00% | 增持 | |
| 300.00K | $324.00K | 0.23% | 增持 | |
| 297.29K | $321.07K | 0.00% | 持有 | |
| 253.42K | $273.69K | 0.00% | 持有 | |
| 194.88K | $210.47K | 0.00% | 增持 | |
| 155.69K | $168.15K | 0.00% | 增持 | |
| 146.83K | $158.57K | 0.00% | 减持 | |
| 114.52K | $123.69K | 0.00% | 持有 | |
| 107.63K | $116.24K | 0.00% | 减持 | |
| 101.66K | $109.79K | 0.00% | 减持 | |
| 100.16K | $108.17K | 0.03% | 持有 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 6.14M | $7.00M | 0.32% | 持有 | |
| 5.51M | $6.28M | 0.35% | 增持 | |
| 2.44M | $2.78M | 0.00% | 增持 | |
| 2.26M | $2.58M | 0.00% | 持有 | |
| 2.14M | $2.44M | 0.00% | 增持 | |
| 2.05M | $2.34M | 0.00% | 增持 | |
| 1.94M | $2.21M | 0.19% | 持有 | |
| 1.80M | $2.05M | 0.24% | 新进 | |
| 1.55M | $1.76M | 1.00% | 持有 | |
| 1.37M | $1.56M | 0.27% | 减持 | |
| 1.31M | $1.49M | 1.01% | 增持 | |
| 1.30M | $1.48M | 0.01% | 减持 | |
| 1.15M | $1.31M | 0.00% | 增持 | |
| 1.00M | $1.14M | 0.18% | 新进 | |
| 891.42K | $1.02M | 0.05% | 持有 | |
| 835.12K | $952.04K | 0.00% | 减持 | |
| 772.13K | $880.22K | 0.06% | 持有 | |
| 681.65K | $783.89K | 0.00% | 减持 | |
| 643.12K | $733.16K | 0.00% | 减持 | |
| 578.58K | $659.95K | 0.00% | 新进 | |
| 578.58K | $659.95K | 0.00% | 增持 | |
| 571.76K | $651.81K | 0.00% | 减持 | |
| 559.45K | $637.77K | 0.00% | 减持 | |
| 559.45K | $637.77K | 0.00% | 减持 | |
| 553.63K | $631.14K | 0.01% | 持有 |
Q1 2026 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 6.14M | $7.74M | 0.39% | 持有 | |
| 2.97M | $3.74M | 1.15% | 持有 | |
| 2.59M | $3.26M | 0.23% | 增持 | |
| 2.34M | $2.95M | 0.00% | 新进 | |
| 2.25M | $2.84M | 0.00% | 增持 | |
| 1.94M | $2.44M | 0.52% | 持有 | |
| 1.85M | $2.33M | 0.00% | 增持 | |
| 1.67M | $2.10M | 0.34% | 增持 | |
| 1.67M | $2.10M | 0.01% | 减持 | |
| 1.55M | $1.95M | 1.25% | 持有 | |
| 1.29M | $1.59M | 1.30% | 增持 | |
| 1.18M | $1.49M | 0.00% | 增持 | |
| 1.18M | $1.49M | 0.00% | 增持 | |
| 1.10M | $1.38M | 0.00% | 增持 | |
| 1.06M | $1.33M | 0.00% | 持有 | |
| 995.97K | $1.25M | 0.00% | 减持 | |
| 891.42K | $1.12M | 0.06% | 增持 | |
| 861.82K | $1.01M | 0.00% | 减持 | |
| 772.13K | $972.88K | 0.06% | 减持 | |
| 718.54K | $905.36K | 0.00% | 增持 | |
| 596.84K | $752.01K | 0.00% | 增持 | |
| 553.63K | $697.57K | 0.01% | 增持 | |
| 532.08K | $670.00K | 0.00% | 持有 | |
| 517.45K | $651.99K | 0.00% | 增持 | |
| 505.74K | $637.23K | 0.00% | 减持 |
Q4 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 6.14M | $7.49M | 0.37% | 增持 | |
| 2.97M | $3.62M | 1.12% | 持有 | |
| 2.82M | $3.44M | 0.00% | 增持 | |
| 2.03M | $2.47M | 0.01% | 减持 | |
| 1.94M | $2.37M | 0.42% | 增持 | |
| 1.62M | $1.97M | 0.14% | 增持 | |
| 1.56M | $1.90M | 0.39% | 增持 | |
| 1.55M | $1.89M | 1.63% | 新进 | |
| 1.25M | $1.52M | 0.00% | 增持 | |
| 1.21M | $1.48M | 0.00% | 减持 | |
| 1.08M | $1.32M | 0.00% | 增持 | |
| 1.07M | $1.31M | 0.00% | 减持 | |
| 1.06M | $1.30M | 0.00% | 减持 | |
| 1.05M | $1.28M | 0.00% | 增持 | |
| 1.00M | $1.22M | 0.05% | 新进 | |
| 953.29K | $1.16M | 0.00% | 增持 | |
| 886.37K | $1.08M | 0.92% | 减持 | |
| 842.02K | $1.03M | 0.05% | 增持 | |
| 711.78K | $868.37K | 0.00% | 增持 | |
| 653.77K | $797.61K | 0.00% | 增持 | |
| 623.70K | $761.00K | 0.07% | 增持 | |
| 592.70K | $723.45K | 0.00% | 增持 | |
| 556.94K | $679.46K | 0.00% | 增持 | |
| 548.96K | $669.73K | 0.00% | 减持 | |
| 545.02K | $664.92K | 0.02% | 增持 |
Q3 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 6.00M | $8.89M | 0.34% | 持有 | |
| 4.50M | $6.67M | 0.03% | 增持 | |
| 4.34M | $6.42M | 0.03% | 新进 | |
| 3.51M | $5.19M | 0.00% | 减持 | |
| 2.97M | $4.39M | 1.36% | 持有 | |
| 2.78M | $4.11M | 0.00% | 减持 | |
| 2.13M | $3.15M | 0.00% | 增持 | |
| 1.59M | $2.36M | 0.23% | 减持 | |
| 1.42M | $2.10M | 0.00% | 减持 | |
| 1.32M | $1.96M | 0.00% | 减持 | |
| 1.10M | $1.62M | 1.45% | 增持 | |
| 1.07M | $1.59M | 0.00% | 增持 | |
| 1.01M | $1.50M | 0.00% | 增持 | |
| 850.00K | $1.26M | 0.52% | 持有 | |
| 824.59K | $1.22M | 0.09% | 新进 | |
| 822.69K | $1.22M | 0.07% | 增持 | |
| 783.25K | $1.16M | 0.00% | 增持 | |
| 708.06K | $1.05M | 0.00% | 增持 | |
| 587.41K | $869.82K | 0.00% | 增持 | |
| 555.08K | $821.51K | 0.00% | 减持 | |
| 537.34K | $795.26K | 0.00% | 减持 | |
| 537.34K | $795.26K | 0.00% | 减持 | |
| 532.08K | $787.00K | 0.00% | 持有 | |
| 466.98K | $691.14K | 0.04% | 增持 | |
| 380.33K | $562.88K | 0.00% | 增持 |
Q2 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 6.00M | $6.96M | 0.35% | 持有 | |
| 3.95M | $4.58M | 0.15% | 减持 | |
| 3.75M | $4.35M | 0.00% | 增持 | |
| 3.00M | $3.48M | 0.00% | 减持 | |
| 2.97M | $3.44M | 1.11% | 持有 | |
| 2.65M | $3.07M | 0.00% | 持有 | |
| 2.35M | $2.72M | 0.01% | 减持 | |
| 2.23M | $2.59M | 0.17% | 增持 | |
| 2.13M | $2.47M | 1.51% | 持有 | |
| 2.13M | $2.47M | 0.00% | 减持 | |
| 1.96M | $2.27M | 0.00% | 增持 | |
| 1.63M | $1.89M | 0.20% | 减持 | |
| 893.73K | $1.04M | 1.04% | 增持 | |
| 850.47K | $986.55K | 0.00% | 新进 | |
| 850.47K | $986.55K | 0.00% | 新进 | |
| 850.00K | $986.00K | 0.64% | 持有 | |
| 837.40K | $971.38K | 0.24% | 增持 | |
| 702.39K | $814.78K | 0.15% | 新进 | |
| 596.70K | $692.17K | 0.00% | 增持 | |
| 582.59K | $676.13K | 0.00% | 减持 | |
| 532.12K | $618.00K | 0.00% | 持有 | |
| 480.53K | $557.41K | 0.00% | 减持 | |
| 455.20K | $528.03K | 0.00% | 增持 | |
| 429.01K | $497.65K | 0.02% | 减持 | |
| 323.41K | $375.16K | 0.00% | 增持 |
新建仓(Q2 2026)
- Lynx1 Capital Management LP 1.80M 股 · $2.05M
- Ikarian Capital, LLC 1.00M 股 · $1.14M
- GEODE CAPITAL MANAGEMENT, LLC 578.58K 股 · $659.95K
- BOOTHBAY FUND MANAGEMENT, LLC 303.00K 股 · $345.42K
- Marquette Asset Management, LLC 174.50K 股 · $198.93K
- Headlands Technologies LLC 33.69K 股 · $38.40K
- Spark Investment Management LLC 22.60K 股 · $25.76K
- NewEdge Advisors, LLC 15.00K 股 · $17.10K
- IFG Advisory, LLC 4 股 · $5
完全清仓(较上季)
- Blue Owl Capital Holdings LP 卖出 2.97M 股 · $3.74M
- Centiva Capital, LP 卖出 432.52K 股 · $544.98K
- Bank of America Corp 卖出 352.71K 股 · $444.41K
- STATE STREET CORP 卖出 253.42K 股 · $319.31K
- Bronte Capital Management Pty Ltd. 卖出 18.61K 股 · $23.45K
- SG Americas Securities, LLC 卖出 12.60K 股 · $16.00K
- HRT FINANCIAL LP 卖出 11.20K 股 · $14.00K
- Vanguard Personalized Indexing Management, LLC 卖出 10.03K 股 · $12.64K
- Tower Research Capital LLC (TRC) 卖出 3.31K 股 · $4.18K
- RHUMBLINE ADVISERS 卖出 2.38K 股 · $3.00K
- Owl Creek Wealth Partners LLC 卖出 2.30K 股 · $2.90K
- MAI Capital Management 卖出 400 股 · $504
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 2.41M | 2.44M | 2.34M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Renaissance Technologies | 2.05M | 2.05M | 1.85M | 1.05M | 1.01M | 199.95K | 152.50K | 27.80K | 101.20K | 253.37K | 75.90K | — | — | — | 138.20K | 20.80K | 94.30K | 105.10K | 105.60K | 30.31K |
| Monaco Asset Management SAM | 2.01M | 1.94M | 1.94M | 1.94M | 822.69K | 702.39K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Prosight Management, LP | 1.60M | 1.37M | 1.67M | 1.56M | 20.49K | 837.40K | 334.26K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BML Capital Management, LLC | 1.55M | 1.55M | 1.55M | 1.55M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Peapod Lane Capital LLC | 1.21M | 1.31M | 1.29M | 886.37K | 1.10M | 893.73K | 642.19K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BlackRock Inc | 1.15M | 1.15M | 1.10M | 1.07M | 1.42M | 2.13M | 5.24M | 5.18M | 5.22M | — | — | — | — | — | — | — | — | — | — | — |
| Marshall Wace | 835.12K | 835.12K | 995.97K | 1.08M | 299.46K | — | 208.53K | 53.88K | — | — | 130.94K | — | 73.92K | — | 37.35K | 65.82K | — | 46.41K | — | — |
| Geode Capital Management | 706.94K | 578.58K | 417.27K | 592.70K | 587.41K | 582.59K | 1.35M | 1.32M | 1.32M | 1.29M | 1.21M | 1.19M | 1.13M | 988.47K | 430.22K | 349.61K | 327.87K | 220.98K | 405.81K | 399.69K |
| Connor, Clark & Lunn Investment Management Ltd. | 536.08K | 536.08K | 517.45K | 371.95K | 24.34K | — | — | — | 34.61K | — | — | — | — | — | — | — | — | — | — | — |
| BESSEMER GROUP INC | 527.31K | 532.08K | 532.08K | 532.08K | 532.08K | 532.12K | 532.12K | 532.17K | 532.17K | 532.08K | 532.08K | 532.08K | 532.08K | — | — | — | — | — | — | — |
| Stonepine Capital Management, LLC | 414.90K | 230.54K | 224.65K | 230.05K | 289.24K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Laurion Capital Management LP | 412.80K | 412.80K | 412.80K | 257.40K | — | — | — | — | — | 2.50M | 3.47M | 3.58M | 3.19M | — | — | — | — | — | — | — |
| Aldebaran Capital, LLC | 403.38K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 385.23K | 341.75K | 339.54K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | 300.00K | 275.00K | 275.00K | 235.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| SEI INVESTMENTS CO | 297.29K | 297.29K | 297.29K | 297.29K | 297.29K | 297.29K | 247.01K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 253.42K | — | 253.42K | 253.42K | 253.83K | 253.83K | 1.28M | 1.39M | 1.40M | 1.38M | 1.32M | 1.34M | 1.32M | — | — | — | — | — | — | — |
| JANE STREET GROUP, LLC | 194.88K | 12.10K | 12.50K | 653.77K | 380.33K | 323.41K | 136.72K | 182.01K | 184.10K | 186.80K | 128.91K | 89.14K | 23.24K | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 155.69K | 153.71K | 153.81K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold PLRX?
As of 2026-Q2, 86 institutional funds reported holding PLRX (PLIANT THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $52.96M.
How many shares of PLRX do institutions own?
13F filers reported 46.45M shares of PLRX, worth $52.96M in aggregate at the end of 2026-Q2.
Is institutional ownership of PLRX rising or falling?
Share counts moved +4.6% versus the prior quarter — accumulation.
Who are the top institutional holders of PLRX?
The largest 13F holders are Paradigm Biocapital Advisors LP, Polar Capital Holdings Plc, First Light Asset Management, LLC, SILVERARC CAPITAL MANAGEMENT, LLC, RA CAPITAL MANAGEMENT, L.P.; the top 25 are ranked at the top of this page.
Who are the major shareholders of PLIANT THERAPEUTICS INC?
The major shareholders of PLIANT THERAPEUTICS INC (PLRX) by reported 13F value are Paradigm Biocapital Advisors LP, Polar Capital Holdings Plc, First Light Asset Management, LLC, SILVERARC CAPITAL MANAGEMENT, LLC, RA CAPITAL MANAGEMENT, L.P., among 290 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.